Recent advances in immunotherapy and monoclonal antibody treatment of cancer

Seminars in oncology nursing

Volumn 16, Issue 4, 2000, Pages 2-12

  Cheng, Jonathan D ^a   Rieger, Paula T ^b   von Mehren, Margaret ^a   Adams, Gregory P ^a   Weiner, Louis M ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

HUMAN; IMMUNOTHERAPY; METASTASIS; NEOPLASM; NURSING; ONCOLOGY NURSING; PATHOLOGY; REVIEW;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOTHERAPY; NEOPLASM METASTASIS; NEOPLASMS; ONCOLOGIC NURSING;

EID: 0034327244     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1053/sonu.2000.19775     Document Type: Article

References (42)

1. Himmelweit B The Collected Papers of Paul Ehrlich 1975 Pergamon Elmsford, NY
2. Pressman D Day ED Blau M The use of paired labeling in the determination of tumor-localizing antibodies Cancer Res 17 1957 845 850
3. Rieger PT Clinical Handbook for Biotherapy 1999 Jones and Bartlett Sudbury, MA 22 23
4. (suppl) Gallucci B The immune system and cancer Oncol Nurs Forum 14 1987 3 12
5. LoBuglio AF Saleh MN Advances in monoclonal antibody therapy of cancer Am J Med Sci 304 1992 214 224
6. Funk JO Cell cycle control Anticancer Res 19 1999 4772 4780
7. Dive C Hickman JA Drug-target interactions: Only the first step in the commitment to a programmed cell death Br J Cancer 64 1991 192 196
8. Sheu BC Hsu SM Ho HN Tumor immunology-When cancer cell meets the immune cells J Formos Med Assoc 98 1999 730 735
9. Kohler G Milstein C Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 1975 495 497
10. Tizard IR Immunology: An introduction ed 3 1992 Saunders College Publishing New York, NY
11. Karius D Marriott MA Immunologic advances in monoclonal antibody therapy: Implications for oncology nursing Oncol Nurs Forum 24 1997 483 494
12. Maloney DG Liles TM Czerwinski DK Phase I clinical trial using escalating single-dose infusion of chimerie anti-CD20 monoclonal antibody (IDEC C2B8) in patients with recurrent B-cell lymphoma Blood 84 1994 2457 2466
13. Kudo T Suzuki M Katayose Y Specific targeting immunotherapy of cancer with bispecific antibodies Tohoku J Exp Med 188 1999 275 288
14. Segal DM Wunderlich JR Targeting of cytotoxic cells with heterocrosslinked antibodies Cancer Invest 6 1988 83 92
15. Weiner LM Moldofsky PJ Gatenby RA Antibody delivery and effector cell activation in a phase II trial of recombinant interferon-γ and murine monoclonal antibody CO17-1A in advanced colorectal carcinoma Cancer Res 48 1988 2568 2573
16. Jain RK Transport of molecules across tumor vasculature Cancer Metastasis Rev 6 1987 559 594
17. Ritz J Schlossman S Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma Blood 59 1982 1 11
18. Schroff R Foon K Beatty S Human antimurine immunoglobulin responses in patients receiving monoclonal antibody therapy Cancer Res Update 45 1985 879 885
19. Kreitman RJ Immunotoxins in cancer therapy Curr Opin Immunol 11 1999 570 578
20. Vitetta ES Stone M Amlot P Phase I immunotoxin trial in patients with B-cell lymphoma Cancer Res 51 1991 4052 4058
21. Grossbard ML Lambert JM Goldmacher VS Anti-B4 blocked ricin: A phase I trial of 7-day continuous infusion in patients with B-cell neoplasms J Clin Oncol 11 1993 726 727
22. Trail PA Willner D Lasch SJ Cure of xenografted human carcinomas by BR 96-doxorubicin immunoconjugates Science 261 1993 212 215
23. Hinman LM Hamann PR Wallace R Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: A novel and potent family of antitumor antibioties Cancer Res 53 1993 3336 3342
24. Zelenetz AD Radioimmunotherapy for lymphoma Curr Opin Oncol 11 1999 375 380
25. Kaminski MS Zasadny KR Francis IR Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody N Engl J Med 329 1993 459 465
26. Grillo-López AJ White CA Varns C Overview of the clinical development of rituximab: First monoclonal antibody approved for the treatment of lymphoma Semin Oncol 26 suppl 14 1999 66 73
27. Hekman A Honsalaar A Vuist WM Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody Cancer Immunol Immunother 32 1991 364 372
28. Miller RA Oscroff AR Stratte PT Monoclonal antibody therapeutic trials in seven patients with T-cell lymphomas Blood 62 1983 988 995
29. McLaughlin P Grillo-López A Link B Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program J Clin Oncol 16 1998 2825 2833
30. Czuezman MS Grillo-López AJ White CA Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy J Clin Oncol 17 1999 268 276
31. (abstr 39) Davis T Maloney D White CA Combination immunotherapy of low grade or follicular (LG/F) non-Hodgkin's lymphoma (NHL) with rituximab and alpha interferon: Interim analysis Proc Am Soc Clin Oncol 17 1998 11a
32. (abstr) Wiseman G Witzig T White C Radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma (NHL) with IDEC-Y2B8 Int J Radiat Oncol Biol Phys 42 suppl 1 1998 130
33. Slamon DJ Clark GM Wong SG Human breast cancer: Correlation of relapse and survival with amplification of the HER2-neu oncogene Science 235 1987 177 182
34. Baselga J Tripathy D Mendelsohn J Phase II study of weekly intravenous trastuzumab in patients with HER2/ neu -overexpressing metastatic breast cancer Semin Oncol 26 suppl 12 1999 78 83
35. Shak S Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatie breast cancer Semin Oncol 26 suppl 12 1999 71 77
36. Ewer MS Gibbs HR Swafford J Cardiotoxicity in patients receiving trastuzumab: Primary toxicity, synergistic or sequential stress, or surveillance artifact Semin Oncol 26 suppl 12 1999 96 101
37. Maloney D Levy R Miller R Monoclonal anti-idiotype therapy of B-cell lymphoma Biol Ther Cancer Updates 2 1992 1 10
38. Miller R Maloney D Warnke R Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody N Engl J Med 306 1982 517 522
39. Haeuber D Recent advances in the management of biotherapy-related side effects: Flu-like syndrome Oncol Nurs Forum 16 suppl 16 1989 35 41
40. Weiner L O'Dwyer J Kitson J Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F-6 recombinant ricin A chain immunoconjugate Cancer Res 49 1989 4062 4067
41. Gould B Borowitz M Groves E Phase I study of an anti-breast cancer immunotoxin by continuous infusion: Report of a targeted toxic effect not predicted by animal studies J Clin Invest 81 1989 775 781
42. Grossbard M Lambert J Goldmacher V Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin Cancer Res 52 1992 4200 4207